Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
1.540
-0.020 (-1.28%)
At close: May 23, 2025, 4:00 PM
1.550
+0.010 (0.66%)
After-hours: May 23, 2025, 4:24 PM EDT
Boundless Bio Employees
Boundless Bio had 64 employees as of December 31, 2024. The number of employees decreased by 8 or -11.11% compared to the previous year.
Employees
64
Change (1Y)
-8
Growth (1Y)
-11.11%
Revenue / Employee
n/a
Profits / Employee
-$1,026,422
Market Cap
34.47M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 64 | -8 | -11.11% |
| Dec 31, 2023 | 72 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
BOLD News
- 15 days ago - Boundless Bio Reports First Quarter 2025 Financial Results and Business Highlights - GlobeNewsWire
- 7 weeks ago - Boundless Bio to Participate in the Needham Virtual Healthcare Conference - GlobeNewsWire
- 2 months ago - Boundless Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights - GlobeNewsWire
- 3 months ago - Boundless Bio to Participate in the Leerink Global Healthcare Conference - GlobeNewsWire
- 3 months ago - Boundless Bio Appoints Robert Doebele, M.D., Ph.D., as Chief Medical Officer - GlobeNewsWire
- 5 months ago - Boundless Bio Announces Pipeline and Leadership Updates - GlobeNewsWire
- 6 months ago - Boundless Bio to Participate in the Piper Sandler Healthcare Conference - GlobeNewsWire
- 7 months ago - Boundless Bio Reports Third Quarter 2024 Financial Results and Business Highlights - GlobeNewsWire